Biotechnology Industry Mergers & Acquisitions News
Mergers & Acquisitions
> Biotechnology Industry Mergers & AcquisitionsBiotechnology Industry Mergers & Acquisitions News is an EIN News Service for global investing professionals. Constantly updated news and information about global investing.
Latest Biotechnology Industry Mergers & Acquisitions News
- News and FDA Updates for Ferro (NYSE:FOE), Boston Scientific (NYSE:BSX), Keryx (Nasdaq:KERX) 7 Nov 2009 08:30 GMT
... community of highly informed investors has Healthcare stock news and updates to its calendar database ... sales occurred prior to Boston Scientific's 2006 acquisition of Guidant. On 11/06/09, Keryx Biopharmaceuticals, Inc. ... business outlook for the remainder of 2009. Biotech investors interested in seeing more details about these ...
- News and FDA Updates for PPD (Nasdaq:PPDI), Imagenetix (OTC:IAGX), Amarin (NASDAQ:AMRN) 7 Nov 2009 08:30 GMT
... community of highly informed investors has Healthcare stock news and updates to its calendar database ... Inc. (Nasdaq:PPDI) announced it has completed its acquisition of Excel PharmaStudies, Inc., the market leader ... Thero as the Company´s Chief Financial Officer. Biotech investors interested in seeing more details about these ...
- www.StockMarketingInc.com: Our Members Know First!! BOFL,AGYS,MBCI,BCRX,BCSI,BNVI 6 Nov 2009 16:45 GMT
... offering to sell shares of its common stock in an underwritten public offering. Raymond James ... of MabCure Inc. (OTC BB: MBCI), a biotech company that has developed a series of highly ... percent. The combination of the S7 Software acquisition and restructuring program is intended to enable ...
- RiskMetrics Group Recommends Stockholders Vote "FOR" Life Sciences Research/Lion Holdings Merger 6 Nov 2009 14:54 GMT
... RiskMetrics Group Recommends Stockholders Vote "FOR" Life Sciences Research/Lion Holdings Merger EAST MILLSTONE, N.J. - (BUSINESS WIRE) - Life ... development services to the pharmaceutical, agrochemical and biotechnology industries. LSR brings leading technology and capability ...
- RiskMetrics Group Recommends Stockholders Vote 'FOR' Life Sciences Research/Lion Holdings Merger 6 Nov 2009 14:32 GMT
... RiskMetrics Group Recommends Stockholders Vote “FOR” Life Sciences Research/Lion Holdings Merger ... Stockholders Vote “FOR” Life Sciences Research/Lion Holdings Merger )--Life Sciences Research, Inc. (NYSE Arca: LSR) announced ... development services to the pharmaceutical, agrochemical and biotechnology industries. LSR brings leading technology and capability ...
- Agennix AG Shares Begin Trading on Frankfurt Stock Exchange 6 Nov 2009 09:34 GMT
... Agennix AG Shares Begin Trading on Frankfurt Stock Exchange MARTINSRIED/MUNICH, GERMANY and PRINCETON, NJ and ... reported on November 23, 2009. Since the merger did not close until after the end of the ... the results will be those of GPC Biotech only. The Company will also provide more ...
- Agennix AG Shares Begin Trading on Frankfurt Stock Exchange Company Provides Business Update 6 Nov 2009 09:28 GMT
... on the Prime Standard of the Frankfurt Stock Exchange under the symbol AGX. The Company ... reported on November 23, 2009. Since the merger did not close until after the end of the ... the results will be those of GPC Biotech only. The Company will also provide more ...
- Our Members Know First!! BOFL,AGYS,MBCI,BCRX,BCSI,BNVI 6 Nov 2009 20:01 GMT
... (M2 PressWIRE Via Acquire Media NewsEdge) STOCK MARKETING INC PRESENTS : (NASDAQ: BOFL - ... of MabCure Inc. (OTC BB: MBCI), a biotech company that has developed a series of highly ... percent. The combination of the S7 Software acquisition and restructuring program is intended to enable ...
- www.StockMarketingInc.com: Breaking News!! JMBA,PLUS,JBLU,NUVA,RAIL,RAND Sign Up Now!! 6 Nov 2009 18:37 GMT
... Grand Island, New York, following their 2008 acquisition of Innovative Biotechnologies International, Inc. ("IBI"). Also participating with Rand ... assays aimed at the infectious disease market." StockMarketingInc.com is a website that profiles stocks of ...
- Oncolytics Biotech(R) Inc. Announces 2009 Third Quarter Results 6 Nov 2009 04:41 GMT
... 2009 (Canada NewsWire via COMTEX) -- Oncolytics Biotech Inc. (TSX:ONC, NASDAQ:ONCY) ("Oncolytics" or the "Company") today ... 1,954,367 3,210,294 8,006,232 Operating 736,024 880,438 2,703,509 Stock based compensation 7,982 17,339 28,163 Foreign exchange ... stock options 342,570 - 715,835 Proceeds from acquisition of private company - 1,800,120 Proceeds from ...
- Covidien Completes Acquisition of Aspect Medical Systems Inc. 6 Nov 2009 21:54 GMT
... Covidien Completes Acquisition of Aspect Medical Systems Inc. DUBLIN - ... delivery. Pursuant to the terms of the merger agreement, Transformer Delaware Corp., an indirect wholly owned ... NewsBlaze, Tags: Business wire, Healthcare, , Health, Biotechnology, Pharmaceuticals, Medical, Consulting, Accounting and other Professional ...
- HRPT Properties Trust Q3 2009 Earnings Call Transcript 6 Nov 2009 06:22 GMT
... well positioned to take advantage of distressed acquisition opportunities. The properties we have purchased this ... the previously announced medical office clinic and biotech laboratory buildings to Senior Housing Properties Trust. We ... and repurchased $14 million of our common stock and over $100 million of our outstanding ...
- Covidien Successfully Completes Tender Offer for Shares of Aspect Medical Systems, Inc. 6 Nov 2009 12:45 GMT
... payment. Pursuant to the terms of the merger agreement, Transformer Delaware Corp. intends to exercise its ... which will permit Covidien to complete the acquisition process by effecting a short-form merger as ... NewsBlaze, Tags: Business wire, Healthcare, , Health, Biotechnology, Pharmaceuticals Covidien Successfully Completes Tender Offer for ...
- Ladenburg Thalmann Reports Third Quarter 2009 Results 6 Nov 2009 22:51 GMT
... First Nine Months of 2009 Due to Acquisition MIAMI--(BUSINESS WIRE)-- Ladenburg Thalmann Financial Services Inc. ... not involve a cash outlay, such as stock-related compensation. EBITDA should be considered in addition ... approximately $80 million for clients in healthcare, biotechnology and other industries. We also grew our ...
- Ladenburg Thalmann Reports Third Quarter 2009 Results (BIZ) 6 Nov 2009 22:50 GMT
... decisions regarding future operating investments and potential acquisitions. The Company believes that EBITDA, as adjusted, ... not involve a cash outlay, such as stock-related compensation. EBITDA should be considered in addition ... approximately $80 million for clients in healthcare, biotechnology and other industries. We also grew our ...
Powered by 
These stories are not published by IPD Group, Inc. and these links will take you to other websites. Some of these websites require their own registration to read their stories.
<<< Please read the disclaimer for more details.>>> | |
|
a digital news provider
reuters.com:
google.com:
bbc.co.uk:
theglobeandmail.com: